ATE332701T1 - Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren - Google Patents
Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatorenInfo
- Publication number
- ATE332701T1 ATE332701T1 AT98963784T AT98963784T ATE332701T1 AT E332701 T1 ATE332701 T1 AT E332701T1 AT 98963784 T AT98963784 T AT 98963784T AT 98963784 T AT98963784 T AT 98963784T AT E332701 T1 ATE332701 T1 AT E332701T1
- Authority
- AT
- Austria
- Prior art keywords
- north american
- american ginseng
- products containing
- fractions
- immune modulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6953497P | 1997-12-12 | 1997-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332701T1 true ATE332701T1 (de) | 2006-08-15 |
Family
ID=22089640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98963784T ATE332701T1 (de) | 1997-12-12 | 1998-12-11 | Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren |
Country Status (13)
Country | Link |
---|---|
US (7) | US6432454B1 (de) |
EP (1) | EP1037645B1 (de) |
JP (2) | JP4458505B2 (de) |
KR (2) | KR100780521B1 (de) |
CN (1) | CN1285752B (de) |
AT (1) | ATE332701T1 (de) |
AU (1) | AU752702B2 (de) |
CA (1) | CA2314453C (de) |
DE (1) | DE69835230T2 (de) |
DK (1) | DK1037645T3 (de) |
HK (1) | HK1032358A1 (de) |
NZ (1) | NZ504975A (de) |
WO (1) | WO1999030725A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432454B1 (en) * | 1997-12-12 | 2002-08-13 | C. V. Technologies, Inc. | Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
PT1161254E (pt) * | 1999-02-25 | 2008-03-20 | Fx Life Sciences Internat Gmbh | Tratamento de doenças auto-imunes com extracto de ginseng americano |
TWI222357B (en) | 2000-01-11 | 2004-10-21 | Medical & Pharm Ind Tech & Dev | Anti-ulcer pharmaceutical composition and the preparation and use thereof |
GB2364640B (en) * | 2000-07-11 | 2002-12-04 | Pharmaceutical Ind Tech & Dev | Anti-ulcer pharmaceutical composition and the preparation thereof |
ES2193874B1 (es) * | 2002-04-03 | 2005-03-01 | Puleva Biotech, S.A. | Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas. |
KR100594353B1 (ko) * | 2002-05-28 | 2006-07-03 | 주식회사 엠디바이오알파 | 신규한 인삼잎 및 줄기 다당체, 그 제조방법 및 그를활성성분으로 함유하는 항암제 및 항암보조제 조성물 |
EP1549300A4 (de) * | 2002-08-23 | 2006-06-21 | Univ New York State Res Found | Stickoxid und seine biomedizinische bedeutung |
CA2900181C (en) | 2003-08-06 | 2019-01-29 | Catherine Tachdjian | Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US20050079234A1 (en) * | 2003-08-27 | 2005-04-14 | Chiang Yang Chi | Compositions comprising herbs and method for immunomodulation |
KR101102480B1 (ko) * | 2004-04-27 | 2012-01-05 | 노부유키 하야시 | 가압 열매체를 이용한 추출방법 및 그 장치 |
KR100456089B1 (ko) * | 2004-07-15 | 2004-11-09 | 박용진 | 항암 활성을 갖는 산삼 추출정제액을 정제하는 방법 및이를 함유하는 조성물 |
CN100509006C (zh) * | 2005-03-25 | 2009-07-08 | 北京欧纳尔生物工程技术有限公司 | 治疗抑郁症的药物组合物及其制法 |
EP1947962B1 (de) * | 2005-11-14 | 2010-10-06 | Unilever N.V. | Essbares produkt, das ginseng-polysaccharide und gesunde bakterien enthält |
BRPI0721682A2 (pt) * | 2007-05-16 | 2013-01-22 | Fx Life Sciences Ag | uso de fraÇÕes de ginseng norte-americano para o tratamento de leucemia |
US20120263806A1 (en) * | 2007-05-16 | 2012-10-18 | Miller Sandra | Uses of North American Ginseng Fractions for Treating Leukemia |
US20090047405A1 (en) * | 2007-08-16 | 2009-02-19 | Conopco, Inc., D/B/A Unilever | Food composition with therapeutic agents |
KR101018989B1 (ko) | 2007-10-31 | 2011-03-07 | 내추럴초이스 (주) | 홍삼박을 이용한 홍삼 다당체의 생산방법 |
CN101888785A (zh) * | 2007-12-07 | 2010-11-17 | 荷兰联合利华有限公司 | 具有免疫刺激效果的食用产品 |
MY158195A (en) | 2008-02-29 | 2016-09-15 | Afexa Life Sciences Inc | Activation of innate and adaptive immune responses by a ginseng extract |
JP2012504121A (ja) * | 2008-09-30 | 2012-02-16 | 株式会社ウンファ | 山参又は人参を含む人参類の形成層由来の植物幹細胞株を有効成分として含む後天性免疫不全症の予防又は治療用組成物 |
KR101067959B1 (ko) * | 2008-10-29 | 2011-09-26 | 구성학 | 감기 및 독감의 치료와 예방에 효과적인 발효유지 조성물의제조방법 |
KR101184389B1 (ko) * | 2009-02-23 | 2012-09-24 | 주식회사 운화 | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 면역증강용 조성물 |
US8574639B2 (en) * | 2010-08-17 | 2013-11-05 | ILHWA Co., Ltd. | Fermented ginseng concentrate having IH-901 |
DK2701714T3 (en) | 2011-04-29 | 2018-10-08 | Nutrileads B V | PROCEDURE FOR ISOLATING POLYSACCHARIDES |
WO2013059942A1 (en) * | 2011-10-28 | 2013-05-02 | Afexa Life Sciences Inc. | Use of a ginseng extract to prevent and treat alopecia areata |
CN109512931A (zh) * | 2012-09-13 | 2019-03-26 | 江中药业股份有限公司 | 改善男性性功能的组合物及其应用 |
CN102928373B (zh) * | 2012-11-26 | 2015-05-13 | 广东省农业科学院花卉研究所 | 一种石斛多糖含量的测定方法及其应用 |
KR102200012B1 (ko) * | 2013-04-02 | 2021-01-08 | (주)아모레퍼시픽 | 인삼열매 추출물을 포함하는 뇌 활성화 조성물 |
WO2014196817A1 (ko) * | 2013-06-04 | 2014-12-11 | 중앙대학교 산학협력단 | 자일리톨을 유효성분으로 함유하는 인플루엔자 바이러스 감염증 예방 또는 치료용 조성물 |
US20150044306A1 (en) | 2013-08-12 | 2015-02-12 | Melvin Mitchell | Process for fractionation and extraction of herbal plant material to isolate extractives for pharmaceuticals and nutraceuticals |
KR102184157B1 (ko) * | 2019-01-08 | 2020-11-30 | 주식회사 바이오에프디엔씨 | 항상성 증가를 통한 피부면역개선, 외부환경에 대한 피부보호 및 피부활력증진을 위한 인삼 유래 테트라펩타이드를 함유하는 화장료 조성물 |
WO2022126261A1 (en) * | 2020-12-15 | 2022-06-23 | Shan Jacqueline J | American ginseng root fractions, processes of their preparation and uses thereof |
CN114848695A (zh) * | 2022-03-25 | 2022-08-05 | 潍坊医学院 | 一种人参稀有皂苷与西洋参多糖的组合物及其应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4912020A (de) * | 1972-05-17 | 1974-02-02 | ||
DE3070086D1 (en) * | 1979-12-03 | 1985-03-14 | Kitasato Inst | A process for preparing substances having interferon inducing activity |
JPS6118722A (ja) * | 1984-07-05 | 1986-01-27 | Wakunaga Seiyaku Kk | 生体防御能亢進剤 |
JPS61109732A (ja) * | 1984-10-31 | 1986-05-28 | Wakunaga Seiyaku Kk | 殺腫瘍性物質誘発剤 |
US4708949A (en) * | 1985-09-24 | 1987-11-24 | Yaguang Liu | Therapeutic composition from plant extracts |
US4706949A (en) * | 1985-12-17 | 1987-11-17 | Dossey Robert L | Vise jaw support system and interchangeable vise jaws therefor |
SU1410322A1 (ru) * | 1986-03-07 | 1996-03-27 | Владивостокский государственный медицинский институт | Способ получения тритерпеновых гликозидов-панаксозидов из корней женьшеня (panax ginseng c.a.mey) |
JPH0643327B2 (ja) * | 1987-03-27 | 1994-06-08 | 株式会社ツムラ | 免疫賦活剤 |
US5071839A (en) * | 1987-11-02 | 1991-12-10 | Yaguang Liu | Safe pharmaceutical composition for decreasing side effects of antiviral drugs and increasing the immune function (SDI) II |
JPH0245499A (ja) * | 1988-08-06 | 1990-02-15 | Wakunaga Pharmaceut Co Ltd | オタネニンジン糖タンパク質およびその用途 |
JPH0245501A (ja) * | 1988-08-06 | 1990-02-15 | Wakunaga Pharmaceut Co Ltd | 竹節ニンジン多糖およびその用途 |
JPH05317041A (ja) * | 1991-06-05 | 1993-12-03 | Nippon Oil Co Ltd | 動物細胞増殖促進剤及び無血清培地 |
JPH0639759A (ja) * | 1992-04-20 | 1994-02-15 | Tokico Ltd | 工業用ロボット装置 |
JPH069418A (ja) * | 1992-06-29 | 1994-01-18 | Nitto Denko Corp | パナキンケコール化合物、及び制癌剤 |
CN1088448A (zh) * | 1992-12-25 | 1994-06-29 | 彭德赐 | 西洋参多糖营养液和西洋参多糖胶囊及其制备方法 |
JPH0782167A (ja) * | 1993-06-29 | 1995-03-28 | Japan Energy Corp | 血清csf活性誘導剤及びその製造方法 |
US5840309A (en) * | 1994-10-03 | 1998-11-24 | La Prairie Sa | Stimulating fibroblasts and/or keratinocytes |
KR100192678B1 (ko) * | 1995-06-07 | 1999-06-15 | 손경식 | 약효가 증강된 가공인삼 제품 |
US6083932A (en) * | 1997-04-18 | 2000-07-04 | Cv Technologies Inc. | Pharmaceutical compositions derived from ginseng and methods of treatment using same |
JP4520033B2 (ja) * | 1997-08-28 | 2010-08-04 | エフエックス ライフ サイエンシズ アクチェンゲゼルシャフト | 薬草抽出物の化学的および薬理学的標準化 |
US6432454B1 (en) * | 1997-12-12 | 2002-08-13 | C. V. Technologies, Inc. | Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
PT1161254E (pt) | 1999-02-25 | 2008-03-20 | Fx Life Sciences Internat Gmbh | Tratamento de doenças auto-imunes com extracto de ginseng americano |
BR0008498A (pt) * | 1999-02-26 | 2002-02-05 | Inspire Pharmaceuticals Inc | Método de promoção de hidratação de mucosas com certos difosfatos de uridina, adenina e citidina e seus análogos |
US6555527B1 (en) * | 1999-08-27 | 2003-04-29 | Korea Atomic Energy Research Institute | Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng |
-
1998
- 1998-11-11 US US09/581,161 patent/US6432454B1/en not_active Expired - Lifetime
- 1998-12-11 NZ NZ504975A patent/NZ504975A/xx not_active IP Right Cessation
- 1998-12-11 CA CA002314453A patent/CA2314453C/en not_active Expired - Lifetime
- 1998-12-11 WO PCT/US1998/025724 patent/WO1999030725A1/en active IP Right Grant
- 1998-12-11 KR KR1020007006333A patent/KR100780521B1/ko not_active IP Right Cessation
- 1998-12-11 KR KR1020077020271A patent/KR100855409B1/ko not_active IP Right Cessation
- 1998-12-11 DE DE69835230T patent/DE69835230T2/de not_active Expired - Lifetime
- 1998-12-11 JP JP2000538705A patent/JP4458505B2/ja not_active Expired - Lifetime
- 1998-12-11 DK DK98963784T patent/DK1037645T3/da active
- 1998-12-11 AU AU19034/99A patent/AU752702B2/en not_active Expired
- 1998-12-11 AT AT98963784T patent/ATE332701T1/de active
- 1998-12-11 EP EP98963784A patent/EP1037645B1/de not_active Expired - Lifetime
- 1998-12-11 CN CN988120690A patent/CN1285752B/zh not_active Expired - Lifetime
-
2001
- 2001-05-02 HK HK01103090.2A patent/HK1032358A1/xx not_active IP Right Cessation
-
2002
- 2002-07-02 US US10/186,733 patent/US20030077341A1/en not_active Abandoned
- 2002-07-02 US US10/187,289 patent/US7067160B2/en not_active Expired - Lifetime
-
2003
- 2003-10-23 US US10/690,628 patent/US7186423B2/en not_active Expired - Lifetime
-
2005
- 2005-04-26 US US11/114,089 patent/US7413756B2/en not_active Expired - Fee Related
-
2008
- 2008-07-16 US US12/173,966 patent/US7763290B2/en not_active Expired - Fee Related
-
2009
- 2009-08-10 JP JP2009186027A patent/JP2009256387A/ja active Pending
-
2010
- 2010-07-19 US US12/839,386 patent/US20100278945A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7763290B2 (en) | 2010-07-27 |
CA2314453C (en) | 2009-03-03 |
US20080286389A1 (en) | 2008-11-20 |
US20100278945A1 (en) | 2010-11-04 |
US6432454B1 (en) | 2002-08-13 |
KR20070093155A (ko) | 2007-09-17 |
US7186423B2 (en) | 2007-03-06 |
JP2009256387A (ja) | 2009-11-05 |
CA2314453A1 (en) | 1999-06-24 |
US20050196471A1 (en) | 2005-09-08 |
WO1999030725A1 (en) | 1999-06-24 |
HK1032358A1 (en) | 2001-07-20 |
AU1903499A (en) | 1999-07-05 |
CN1285752B (zh) | 2011-05-25 |
US7413756B2 (en) | 2008-08-19 |
EP1037645A4 (de) | 2004-03-03 |
DE69835230T2 (de) | 2007-07-05 |
DE69835230D1 (de) | 2006-08-24 |
DK1037645T3 (da) | 2006-11-06 |
US20040137087A1 (en) | 2004-07-15 |
US20030124207A1 (en) | 2003-07-03 |
JP2002508329A (ja) | 2002-03-19 |
AU752702B2 (en) | 2002-09-26 |
US20030077341A1 (en) | 2003-04-24 |
US7067160B2 (en) | 2006-06-27 |
NZ504975A (en) | 2004-02-27 |
EP1037645A1 (de) | 2000-09-27 |
JP4458505B2 (ja) | 2010-04-28 |
KR100855409B1 (ko) | 2008-08-29 |
CN1285752A (zh) | 2001-02-28 |
KR100780521B1 (ko) | 2007-11-29 |
KR20010032984A (ko) | 2001-04-25 |
EP1037645B1 (de) | 2006-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE332701T1 (de) | Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren | |
ATE261337T1 (de) | Verfahren zur herstellung von morphologisch einheitlichen mikro- und nanopartikeln mittels eines mikromischers | |
HUP0103758A2 (hu) | Neurotróf faktorok | |
WO2004001007A3 (en) | Buffered formulations for concentrating antibodies and methods of use thereof | |
MXPA02008265A (es) | Concentracion y estimulacion simultanea de calulas. | |
ATE296315T1 (de) | Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung | |
DE69939312D1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
ATE226960T1 (de) | Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung | |
NO20050091L (no) | Fremgangsmater for fremstilling av fibrinogen | |
ATE306252T1 (de) | Verfahren zur herstellung kristalliner partikel zur inhalation | |
DE69325393D1 (de) | Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen | |
DE69920945D1 (de) | Verfahren zur herstellung von arzneistoffpartikeln | |
DE60133882D1 (de) | Mutante bakteriestämme vom genus sphingonomas die defizient in der herstellung von polyhydroxybutyrate sind, und verfahren zur klärung von sphinganen | |
DE10193689D2 (de) | Retardpartikeldispersion | |
EP1423414A4 (de) | Neue depsipeptide und verfahren zu deren herstellung | |
ES2177316T3 (es) | Anticuerpos humanos antifacotores ix/ixa. | |
DE68908223D1 (de) | Verfahren zur herstellung von sehr reiner, dichter grossteiliger kieselsaeure. | |
ATE404674T1 (de) | Verfahren zur herstellung von ergosterol und dessen zwischenprodukten mittels rekombinanter hefen | |
DE60024997D1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
ATE442361T1 (de) | Verfahren zur herstellung kristalliner formen von orlistat | |
DE60125528D1 (de) | Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung | |
DE69535267D1 (de) | Verwendung zur verabreichung von östrogen | |
DE69333992D1 (de) | Verfahren zur herstellung eines sets von kombinatorischen polypeptidantigenen | |
DE50200711D1 (de) | Substanzen zur therapie von erkrankungen, die durch hochproliferierende zellen verursacht werden | |
ATE174756T1 (de) | Zyklische anti-tumorpromotor-verbindungen, zusammensetzungen und verfahren zur herstellung sowie ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1037645 Country of ref document: EP |
|
EEIH | Change in the person of patent owner |